PREFERENTIAL INHIBITION OF ACETYLCHOLINESTERASE MOLECULAR-FORMS IN RAT-BRAIN

被引:32
作者
OGANE, N
GIACOBINI, E
MESSAMORE, E
机构
[1] Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, 62794-9230, Illinois
关键词
ACETYLCHOLINESTERASE (ACHE); MOLECULAR FORMS; ACHE INHIBITORS; HEPTYL-PHYSOSTIGMINE; SUCROSE DENSITY GRADIENT SEDIMENTATION;
D O I
10.1007/BF00969897
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of eight different acetylcholinesterase inhibitors (AChEIs) on the activity of acetylcholinesterase (AChE) molecular forms was investigated. Aqueous-soluble and detergent-soluble AChE molecular forms were separated from rat brain homogenate by sucrose density sedimentation. The bulk of soluble AChE corresponds to globular tetrameric (G4), and monomeric (G1) forms. Heptyl-physostigmine (HEP) and diisopropylfluorophosphate were more selective for the G1 than for the G4 form in aqueous-soluble extract. Neostigmine showed slightly more selectivity for the G1 form both in aqueous- and detergent-soluble extracts. Other drugs such as physostigmine, echothiophate, BW284C51, tetrahydroaminoacridine, and metrifonate inhibited both aqueous- and detergent-soluble AChE molecular forms with similar potency. Inhibition of aqueous-soluble AChE by HEP was highly competitive with Triton X-100 in a gradient, indicating that HEP may bind to a detergent-sensitive non-catalytic site of AChE. These results suggest a differential sensitivity among AChE molecular forms to inhibition by drugs through an allosteric mechanism. The application of these properties in developing AChEIs for treatment of Alzheimer disease is considered.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 34 条
[21]   ACETYLCHOLINESTERASE ACTIVITY IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE AND SENILE DEMENTIA [J].
NAKANO, S ;
KATO, T ;
NAKAMURA, S ;
KAMEYAMA, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1986, 75 (02) :213-223
[22]  
Pomponi M, 1990, Aging (Milano), V2, P125
[23]  
RAKONCZAY Z, 1986, NEUROMETHODS NEUROTR, V5, P319
[24]   SOLUBILIZATION AND PHYSICOCHEMICAL CHARACTERIZATION OF RAT-BRAIN ACETYLCHOLINESTERASE - DEVELOPMENT AND MATURATION OF ITS MOLECULAR-FORMS [J].
RIEGER, F ;
VIGNY, M .
JOURNAL OF NEUROCHEMISTRY, 1976, 27 (01) :121-129
[25]  
ROUFOGALIS BD, 1972, MOL PHARMACOL, V8, P41
[26]   MOLECULAR-FORMS OF ACETYLCHOLINESTERASE IN SUBCORTICAL AREAS OF NORMAL AND ALZHEIMER-DISEASE BRAIN [J].
SIEK, GC ;
KATZ, LS ;
FISHMAN, EB ;
KOROSI, TS ;
MARQUIS, JK .
BIOLOGICAL PSYCHIATRY, 1990, 27 (06) :573-580
[27]  
SKAU KA, 1981, PHARMACOLOGIST, V23, P224
[28]  
SKAU KA, 1982, PHARMACOLOGIST, V24, P221
[29]   AN AMPHIPHILE-DEPENDENT FORM OF HUMAN-BRAIN CAUDATE-NUCLEUS ACETYLCHOLINESTERASE - PURIFICATION AND PROPERTIES [J].
SORENSEN, K ;
GENTINETTA, R ;
BRODBECK, U .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (04) :1050-1060
[30]  
TAYLOR PB, 1981, J BIOL CHEM, V256, P3827